Trial intelligence / Profile preview

Dexmedetomidine for Delirium Prevention After Cardiac Surgery

NCT03477344Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Jan 2019
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in delirium, sponsored by Centre Hospitalier Universitaire de Brest. Started Jan 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

delirium

Beyond the preview

Go deeper on NCT03477344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03477344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call